Design, preparation and biological evaluation of libraries of marocyclic delta opioid receptor agonists for the treatment of pain

用于治疗疼痛的大环δ阿片受体激动剂库的设计、制备和生物学评价

• 批准号: 468428-2014
• 负责人: Dory, Yves
• 金额: $ 3.15万
• 依托单位: Université de Sherbrooke
• 依托单位国家: 加拿大
• 项目类别: Collaborative Research and Development Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=618943
• 关键词: Design; preparation; biological; evaluation; libraries

The overall goal of this research proposal is to provide novel peptide-based DOPr (delta opioid receptor) agonists for the treatment of chronic pain. Although numerous peptide and non-peptide DOPr agonists have been developed over the past 30 years, very few compounds have reached clinical trials and, most importantly, nowadays none of them have been approved for clinical use. Originality and novelty of this research proposal relies on the fact that we will synthesize libraries of novel cyclic enkephalin analogs which will ultimately afford drug-like molecules with better stability, enhanced delivery and greater selectivity toward DOPr.As a matter of fact, we already have synthesized such macrolactams with improved affinity for DOPr and our industrial collaborator, Cyclenium Pharma, will help us preparing biased libraries of cyclic peptides structurally related to our already potent molecules. Furthermore, our computational analysis of structure-activity and structure-selectivity relationships and PET imaging approaches will assist us during the design of the libraries.

该研究建议的总体目标是提供基于肽的新型DOPR（Delta阿片受体）激动剂来治疗慢性疼痛。尽管在过去30年中已经开发了许多肽和非肽Dopr激动剂，但很少有化合物进行了临床试验，最重要的是，如今，它们都没有被批准用于临床使用。 Originality and novelty of this research proposal relies on the fact that we will synthesize libraries of novel cyclic enkephalin analogs which will ultimately afford drug-like molecules with better stability, enhanced delivery and greater selectivity toward DOPr.As a matter of fact, we already have synthesized such macrolactams with improved affinity for DOPr and our industrial collaborator, Cyclenium Pharma, will help us preparing biased环状肽的库在结构上与我们已经有效的分子相关。此外，我们对结构活性和结构选择关系和宠物成像方法的计算分析将在图书馆设计期间有助于我们。